The neurochemical mechanism of rebound psychosis in Parkinson's disease
Identifieur interne : 004D91 ( Main/Merge ); précédent : 004D90; suivant : 004D92The neurochemical mechanism of rebound psychosis in Parkinson's disease
Auteurs : Spiridon Papapetropoulos [États-Unis] ; Deborah C. Mash [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-04.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antipsychotic Agents, Clozapine, Dibenzothiazepines.
- drug therapy : Psychotic Disorders.
- etiology : Psychoses, Substance-Induced, Psychotic Disorders.
- psychology : Parkinson Disease.
- Humans.
Abstract
A reply to this letter has been published in Movement DisordersMov Disord (2005) 20 (4) 515.
Url:
DOI: 10.1002/mds.20438
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004200
- to stream Istex, to step Curation: 004200
- to stream Istex, to step Checkpoint: 002114
- to stream PubMed, to step Corpus: 003110
- to stream PubMed, to step Curation: 003110
- to stream PubMed, to step Checkpoint: 002F40
- to stream Ncbi, to step Merge: 001191
- to stream Ncbi, to step Curation: 001191
- to stream Ncbi, to step Checkpoint: 001191
Links to Exploration step
ISTEX:FE0693A54A21F8639CB502365BC025523F49A883Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The neurochemical mechanism of rebound psychosis in Parkinson's disease</title>
<author><name sortKey="Papapetropoulos, Spiridon" sort="Papapetropoulos, Spiridon" uniqKey="Papapetropoulos S" first="Spiridon" last="Papapetropoulos">Spiridon Papapetropoulos</name>
</author>
<author><name sortKey="Mash, Deborah C" sort="Mash, Deborah C" uniqKey="Mash D" first="Deborah C." last="Mash">Deborah C. Mash</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FE0693A54A21F8639CB502365BC025523F49A883</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20438</idno>
<idno type="url">https://api.istex.fr/document/FE0693A54A21F8639CB502365BC025523F49A883/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">004200</idno>
<idno type="wicri:Area/Istex/Curation">004200</idno>
<idno type="wicri:Area/Istex/Checkpoint">002114</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Papapetropoulos S:the:neurochemical:mechanism</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15747367</idno>
<idno type="wicri:Area/PubMed/Corpus">003110</idno>
<idno type="wicri:Area/PubMed/Curation">003110</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F40</idno>
<idno type="wicri:Area/Ncbi/Merge">001191</idno>
<idno type="wicri:Area/Ncbi/Curation">001191</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001191</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Papapetropoulos S:the:neurochemical:mechanism</idno>
<idno type="wicri:Area/Main/Merge">004D91</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The neurochemical mechanism of rebound psychosis in Parkinson's disease</title>
<author><name sortKey="Papapetropoulos, Spiridon" sort="Papapetropoulos, Spiridon" uniqKey="Papapetropoulos S" first="Spiridon" last="Papapetropoulos">Spiridon Papapetropoulos</name>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Miami School of Medicine, Miami</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mash, Deborah C" sort="Mash, Deborah C" uniqKey="Mash D" first="Deborah C." last="Mash">Deborah C. Mash</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Miami School of Medicine, Miami</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-04">2005-04</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="515">515</biblScope>
<biblScope unit="page" to="515">515</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">FE0693A54A21F8639CB502365BC025523F49A883</idno>
<idno type="DOI">10.1002/mds.20438</idno>
<idno type="ArticleID">MDS20438</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antipsychotic Agents (adverse effects)</term>
<term>Clozapine (adverse effects)</term>
<term>Dibenzothiazepines (adverse effects)</term>
<term>Humans</term>
<term>Parkinson Disease (psychology)</term>
<term>Psychoses, Substance-Induced (etiology)</term>
<term>Psychotic Disorders (drug therapy)</term>
<term>Psychotic Disorders (etiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Clozapine</term>
<term>Dibenzothiazepines</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Psychoses, Substance-Induced</term>
<term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A reply to this letter has been published in Movement DisordersMov Disord (2005) 20 (4) 515.</div>
</front>
</TEI>
<double doi="10.1002/mds.20438"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The neurochemical mechanism of rebound psychosis in Parkinson's disease</title>
<author><name sortKey="Papapetropoulos, Spiridon" sort="Papapetropoulos, Spiridon" uniqKey="Papapetropoulos S" first="Spiridon" last="Papapetropoulos">Spiridon Papapetropoulos</name>
</author>
<author><name sortKey="Mash, Deborah C" sort="Mash, Deborah C" uniqKey="Mash D" first="Deborah C." last="Mash">Deborah C. Mash</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FE0693A54A21F8639CB502365BC025523F49A883</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20438</idno>
<idno type="url">https://api.istex.fr/document/FE0693A54A21F8639CB502365BC025523F49A883/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">004200</idno>
<idno type="wicri:Area/Istex/Curation">004200</idno>
<idno type="wicri:Area/Istex/Checkpoint">002114</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Papapetropoulos S:the:neurochemical:mechanism</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The neurochemical mechanism of rebound psychosis in Parkinson's disease</title>
<author><name sortKey="Papapetropoulos, Spiridon" sort="Papapetropoulos, Spiridon" uniqKey="Papapetropoulos S" first="Spiridon" last="Papapetropoulos">Spiridon Papapetropoulos</name>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Miami School of Medicine, Miami</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mash, Deborah C" sort="Mash, Deborah C" uniqKey="Mash D" first="Deborah C." last="Mash">Deborah C. Mash</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Miami School of Medicine, Miami</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-04">2005-04</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="515">515</biblScope>
<biblScope unit="page" to="515">515</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">FE0693A54A21F8639CB502365BC025523F49A883</idno>
<idno type="DOI">10.1002/mds.20438</idno>
<idno type="ArticleID">MDS20438</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A reply to this letter has been published in Movement DisordersMov Disord (2005) 20 (4) 515.</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The neurochemical mechanism of rebound psychosis in Parkinson's disease.</title>
<author><name sortKey="Papapetropoulos, Spiridon" sort="Papapetropoulos, Spiridon" uniqKey="Papapetropoulos S" first="Spiridon" last="Papapetropoulos">Spiridon Papapetropoulos</name>
</author>
<author><name sortKey="Mash, Deborah C" sort="Mash, Deborah C" uniqKey="Mash D" first="Deborah C" last="Mash">Deborah C. Mash</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="doi">10.1002/mds.20438</idno>
<idno type="RBID">pubmed:15747367</idno>
<idno type="pmid">15747367</idno>
<idno type="wicri:Area/PubMed/Corpus">003110</idno>
<idno type="wicri:Area/PubMed/Curation">003110</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F40</idno>
<idno type="wicri:Area/Ncbi/Merge">001191</idno>
<idno type="wicri:Area/Ncbi/Curation">001191</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001191</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Papapetropoulos S:the:neurochemical:mechanism</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The neurochemical mechanism of rebound psychosis in Parkinson's disease.</title>
<author><name sortKey="Papapetropoulos, Spiridon" sort="Papapetropoulos, Spiridon" uniqKey="Papapetropoulos S" first="Spiridon" last="Papapetropoulos">Spiridon Papapetropoulos</name>
</author>
<author><name sortKey="Mash, Deborah C" sort="Mash, Deborah C" uniqKey="Mash D" first="Deborah C" last="Mash">Deborah C. Mash</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antipsychotic Agents (adverse effects)</term>
<term>Clozapine (adverse effects)</term>
<term>Dibenzothiazepines (adverse effects)</term>
<term>Humans</term>
<term>Parkinson Disease (psychology)</term>
<term>Psychoses, Substance-Induced (etiology)</term>
<term>Psychotic Disorders (drug therapy)</term>
<term>Psychotic Disorders (etiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Clozapine</term>
<term>Dibenzothiazepines</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Psychoses, Substance-Induced</term>
<term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D91 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004D91 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:FE0693A54A21F8639CB502365BC025523F49A883 |texte= The neurochemical mechanism of rebound psychosis in Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |